ICLR - Company ID 0001060955
ICON PLC trades as ICLR and has a market capitalization of $12.79 B, making it the #812 largest US-listed company by market value. This page tracks ICON PLC through 781 SEC filings, with financial statements and metrics updated as new reports are filed.
Research snapshot
Updated
2026-07-09
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.
Next research step
Over the last 9 fiscal years ICON PLC's revenue grew from $1.57B to $8.28B, a compound annual growth rate of 20.3%. Net profit margin compressed from 15.2% to 9.6% over the same period - every figure below comes from the company's audited annual filings.
Dig into the full income statement, balance sheet, and cash flow statement with annual and quarterly views.
| Filing | Type | Filed |
|---|---|---|
| 6-K | - | 2026-05-26 |
| Insider trade | 4 | 2026-05-15 |
| Insider trade | 4 | 2026-05-15 |
| Insider trade | 4 | 2026-05-15 |
| SCHEDULE 13G/A | - | 2026-05-15 |
| SCHEDULE 13G/A | - | 2026-05-15 |
| SCHEDULE 13G | - | 2026-05-15 |
| SCHEDULE 13G | - | 2026-05-06 |
ICON expands US early phase research capabilities with new clinic and outpatient centres | ICON plc
ICON Provides Update on Audit Committee Investigation and Timing of Fourth Quarter and Full Year 2025 Financial Results | ICON plc
ICON and Advarra Introduce New ‘Research-Ready,’ Connected Site Network Model | ICON plc
ICON plc Provides Update on Timing of Fourth Quarter and Full Year 2025 Earnings Results and Investigation into Accounting Practices | ICON plc
ICON’s Accellacare Site Network Expands Oncology Research Capabilities With New Cancer Institute Partnership | ICON plc
The largest companies sharing ICON PLC's SEC industry classification (services-commercial physical & biological research).
ICON PLC (ICLR) has a market capitalization of $12.79 B as of 2026-07-09, ranking #812 among US-listed companies.